Pricing Log in Create free account

MediWound Ltd. (MDWD) vs Oramed Pharmaceuticals Inc. (ORMP)

MediWound Ltd. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. MediWound Ltd. is the larger, with a market value of $184.0M against $160.6M — 1.1× the size. MediWound Ltd. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 48.8% against −40.3%. Oramed Pharmaceuticals Inc. has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (−3.40% vs −6,551.8%). Across the 17 metrics below, Oramed Pharmaceuticals Inc. leads on 13 and MediWound Ltd. on 4.

Valuation

Metric MDWD ORMP Biotechnology median
P/E n/m 0.91 10.60
P/S 15.48 39.40 9.40
P/B 5.15 0.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 12.58 26.81 9.02
Earnings yield (11.23%) 109.59% (32.88%)
Free cash flow yield (15.56%) (3.29%) (23.13%)

Profitability

Metric MDWD ORMP Biotechnology median
Gross margin 15.46% 32.31% 68.51%
Operating margin (267.75%) 0.00% 0.00%
Net margin (170.10%) 0.00% 0.00%
Free cash flow margin (240.47%) 0.00% 0.00%
Return on equity (75.42%) 73.90% (51.96%)
Return on assets (29.06%) 65.52% (46.06%)
Return on invested capital (6,551.77%) (3.40%) 0.00%

Growth

Metric MDWD ORMP Biotechnology median
Revenue growth (TTM) (40.26%) 48.76% 6.76%
EPS growth (last fiscal year) 30.69% 412.50% 29.88%
Revenue growth, 5-year CAGR (4.87%) (5.85%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD ORMP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 4.98 4.97
Net debt to EBITDA 2.27 8.41 1.01

Dividend

Metric MDWD ORMP Biotechnology median
Dividend yield — 6.48% 0.41%
Payout ratio — 0.06 —

Size

Metric MDWD ORMP Biotechnology median
Market cap 183.97m 160.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack